Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics

View through CrossRef
Mutations within the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are the most common genetic cause of autosomal and sporadic Parkinson’s disease (PD). LRRK2 is a large multidomain kinase that has reported interactions with several membrane proteins, including Rab and Endophilin, and has recently been proposed to function as a regulator of vesicular trafficking. It is unclear whether or how the spatiotemporal organization of the protein is altered due to LRRK2 activity. Therefore, we utilized fluctuation-based microscopy along with FLIM/FRET to examine the cellular properties and membrane recruitment of WT LRRK2-GFP (WT) and the PD mutant G2019S LRRK2-GFP (G2019S). We show that both variants can be separated into two distinct populations within the cytosol; a freely diffusing population associated with monomer/dimer species and a slower, likely vesicle-bound population. G2019S shows a significantly higher propensity to self-associate in both the cytosol and membrane regions when compared to WT. G2019S expression also resulted in increased hetero-interactions with Endophilin A1 (EndoA1), reduced cellular vesicles, and altered clathrin puncta dynamics associated with the plasma membrane. This finding was associated with a reduction in transferrin endocytosis in cells expressing G2019S, which indicates disruption of endocytic protein recruitment near the plasma membrane. Overall, this study uncovered multiple dynamic alterations to the LRRK2 protein as a result of the G2019S mutation—all of which could lead to neurodegeneration associated with PD.
Title: Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics
Description:
Mutations within the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are the most common genetic cause of autosomal and sporadic Parkinson’s disease (PD).
LRRK2 is a large multidomain kinase that has reported interactions with several membrane proteins, including Rab and Endophilin, and has recently been proposed to function as a regulator of vesicular trafficking.
It is unclear whether or how the spatiotemporal organization of the protein is altered due to LRRK2 activity.
Therefore, we utilized fluctuation-based microscopy along with FLIM/FRET to examine the cellular properties and membrane recruitment of WT LRRK2-GFP (WT) and the PD mutant G2019S LRRK2-GFP (G2019S).
We show that both variants can be separated into two distinct populations within the cytosol; a freely diffusing population associated with monomer/dimer species and a slower, likely vesicle-bound population.
G2019S shows a significantly higher propensity to self-associate in both the cytosol and membrane regions when compared to WT.
G2019S expression also resulted in increased hetero-interactions with Endophilin A1 (EndoA1), reduced cellular vesicles, and altered clathrin puncta dynamics associated with the plasma membrane.
This finding was associated with a reduction in transferrin endocytosis in cells expressing G2019S, which indicates disruption of endocytic protein recruitment near the plasma membrane.
Overall, this study uncovered multiple dynamic alterations to the LRRK2 protein as a result of the G2019S mutation—all of which could lead to neurodegeneration associated with PD.

Related Results

Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease
OBJECTIVE The objective of this study was to evaluate clinical features and response to deep brain stimulation (DBS) in G2019S LRRK2-Parkinson disease (LRRK2-PD) and idiopathic PD ...
Membrane traffic defects in Parkinson's disease
Membrane traffic defects in Parkinson's disease
Défauts de trafic membranaire dans la maladie de Parkinson La maladie de Parkinson (MP) est une maladie neurodégénérative progressive caractérisée par la mort de ne...
Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease
AbstractObjectiveTo evaluate sex differences and the relative effect of G2019S LRRK2 mutations in Parkinson's disease (PD).Methods530 LRRK2 PD carriers and 759 noncarrier PD (idiop...
Multiple sclerosis in LRRK2 G2019S Parkinson’s disease and isolated nigral degeneration in a homozygous variant carrier
Multiple sclerosis in LRRK2 G2019S Parkinson’s disease and isolated nigral degeneration in a homozygous variant carrier
BackgroundLRRK2 variants have been associated with immune dysregulation as well as immune-related disorders such as IBD. A possible relationship between multiple sclerosis (MS) and...
LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines
LRRK2 expression in normal and pathologic human gut and in rodent enteric neural cell lines
Abstract Leucine‐rich repeat kinase 2 (LRRK2) gene, which is the gene most commonly associated with Parkinson's disease (...
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
The LRRK2 mutation is a major causal mutation in familial Parkinson’s disease. Although LRRK2 contains functional GTPase and kinase domains and their activities are altered by path...
LRRK2/LRRK1 interactions modulate Rab7 activity and inhibit lysosomal exocytosis
LRRK2/LRRK1 interactions modulate Rab7 activity and inhibit lysosomal exocytosis
Abstract Mutations in the LRRK2 gene are the most common genetic cause of both familial and sporadic Parkinso...
LRRK2 in Infection: Friend or Foe?
LRRK2 in Infection: Friend or Foe?
Abstract In the field of Parkinson’s disease (PD) research, leucine-rich repeat kinase 2 (LRRK2) remains one of the most enigmatic kinases. LRRK2 pathogenic mutat...

Back to Top